Cingulate (CING) Expected to Announce Quarterly Earnings on Monday

Cingulate (NASDAQ:CING) will likely be issuing its quarterly earnings data before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($1.48) per share for the quarter.

Cingulate Stock Down 3.2 %

Shares of CING stock opened at $3.96 on Friday. The stock’s 50-day moving average is $4.34 and its two-hundred day moving average is $4.55. Cingulate has a 1 year low of $1.80 and a 1 year high of $20.83.

Wall Street Analyst Weigh In

CING has been the topic of several research reports. Roth Capital raised Cingulate to a “strong-buy” rating in a report on Friday, January 10th. Roth Mkm initiated coverage on Cingulate in a report on Friday, January 10th. They set a “buy” rating and a $12.00 price objective on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and set a $20.00 price objective on shares of Cingulate in a report on Thursday, March 6th.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.